(Q82992297)
Statements
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity (English)
Lars Bullinger
Andrea Corbacioglu
Mathijs A Sanders
Claudia A J Erpelinck
Bas J Wouters
Sonja C van der Poel-van de Luytgaarde
Frederik Damm
Jürgen Krauter
Arnold Ganser
Richard F Schlenk
Bob Löwenberg
Ruud Delwel
Hartmut Döhner
Peter J M Valk
Konstanze Döhner
21 December 2010